首页> 外文OA文献 >PDB50 Cost-Effectiveness Analysis of Exenatide Once-Weekly Versus Dulaglutide, Liraglutide and Lixisenatide for the Treatment of Type 2 Diabetes Mellitus: An Analysis from the UK NHS Perspective

【2h】

PDB50 Cost-Effectiveness Analysis of Exenatide Once-Weekly Versus Dulaglutide, Liraglutide and Lixisenatide for the Treatment of Type 2 Diabetes Mellitus: An Analysis from the UK NHS Perspective

机译：艾塞那肽每周一次与杜拉鲁肽，利拉鲁肽和利西拉来肽治疗2型糖尿病的PDB50成本-效果分析：从英国NHS角度进行的分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Charokopou M; Chuang L; Verheggen B; Gibson D; Grandy S; Kartman B;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Management of Patients with Type 2 Diabetes with Once-Weekly Semaglutide Versus Dulaglutide, Exenatide ER, Liraglutide and Lixisenatide: A Cost-Effectiveness Analysis in the Danish Setting [J] . Peter G?de, Pierre Johansen, Christian Klyver Tikkanen, Diabetes therapy . 2019,第4期

机译：每周两次塞马鲁肽与杜拉鲁肽，艾塞那肽ER，利拉鲁肽和利西拉来肽对2型糖尿病患者的管理：丹麦环境中的成本-效果分析
2. Treatment patterns in patients with type 2 diabetes mellitus treated with glucagon-like peptide-1 receptor agonists: Higher adherence and persistence with dulaglutide compared with once-weekly exenatide and liraglutide [J] . Alatorre Carlos, Lando Laura Fernandez, Yu Maria, Diabetes, obesity & metabolism . 2017,第7期

机译：用胰高血糖素肽-1受体激动剂治疗2型糖尿病患者的治疗模式：与杜拉蛋白质相比，与杜拉替纳肽和左旋蛋白质相比，较高的粘附和持续性
3. The Short-Term Cost-Effectiveness of Once-Weekly Semaglutide Versus Once-Daily Sitagliptin and Once-Weekly Dulaglutide for the Treatment of Patients with Type?2 Diabetes: A Cost of Control Analysis in Spain [J] . Josep Vidal, Samuel J. P. Malkin, Barnaby Hunt, Diabetes therapy . 2020,第2期

机译：每周半蛋白质的短期成本效果与一次每日SitaGliptin和一次每周达拉蛋白质进行一次治疗2型糖尿病患者：西班牙的控制分析成本
4. Comparative Analysis of Machine Learning Models for Diabetes Mellitus Type 2 Prediction [C] . Leila Ismail, Huned Materwala International Conference on Computational Science and Computational Intelligence . 2020

机译：糖尿病机器学习模型的比较分析2型预测
5. A 4-month randomized controlled clinical trial of adjuvant Exenatide or Pramlintide versus insulin alone in pediatric type 1 diabetes mellitus: Effect on glycemic control. [D] . Withycombe, Sarah Elizabeth. 2010

机译：儿科1型糖尿病患者中艾塞那肽或普兰林肽与单独使用胰岛素的4个月随机对照临床试验：对血糖控制的影响。
6. Correction to: Management of Patients with Type 2 Diabetes with Once-Weekly Semaglutide Versus Dulaglutide Exenatide ER Liraglutide and Lixisenatide: A Cost-Effectiveness Analysis in the Danish Setting [O] . Peter Gæde, Pierre Johansen, Christian Klyver Tikkanen, 2019

机译：校正至：每周两次Semaglutide相对于DulaglutideExenatide ERLiraglutide和Lixisenatide的2型糖尿病患者的治疗：丹麦环境中的成本-效果分析
7. Correction to: Management of Patients with Type 2 Diabetes with Once-Weekly Semaglutide Versus Dulaglutide, Exenatide ER, Liraglutide and Lixisenatide: A Cost-Effectiveness Analysis in the Danish Setting [O] . Peter Gæde, Pierre Johansen, Christian Klyver Tikkanen, 2019

机译：矫正：2型糖尿病患者的患者，每周一次半蛋白质，丁蛋白酰胺，羊毛蛋白质和丽昔肽和丽甲酰胺：丹麦地区的成本效益分析

PDB50 Cost-Effectiveness Analysis of Exenatide Once-Weekly Versus Dulaglutide, Liraglutide and Lixisenatide for the Treatment of Type 2 Diabetes Mellitus: An Analysis from the UK NHS Perspective

著录项

相似文献

相关主题

期刊订阅